|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.52 USD | -4.43% |
|
+0.95% | -14.56% |
| Capitalization | 5.68B 4.9B 4.43B 4.23B 7.72B 523B 7.93B 52.33B 20.86B 250B 21.29B 20.85B 901B | P/E ratio 2026 * |
-134x | P/E ratio 2027 * | 41.9x |
|---|---|---|---|---|---|
| Enterprise value | 3.96B 3.42B 3.09B 2.95B 5.39B 365B 5.54B 36.52B 14.56B 175B 14.86B 14.55B 629B | EV / Sales 2026 * |
4.04x | EV / Sales 2027 * | 3.26x |
| Free-Float |
97.66% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: PTC Therapeutics, Inc.
| 1 day | -4.33% | ||
| 1 week | +0.95% | ||
| Current month | -4.82% | ||
| 1 month | -8.49% | ||
| 3 months | -13.97% | ||
| 6 months | +6.46% | ||
| Current year | -14.56% |
| 1 week | 61.43 |  | 71 |
| 1 month | 61.43 | | 72.54 |
| Current year | 61.43 | | 80.18 |
| 1 year | 35.95 | | 87.5 |
| 3 years | 17.53 | | 87.5 |
| 5 years | 17.53 | | 87.5 |
| 10 years | 4.03 | | 87.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Klein
CEO | Chief Executive Officer | 54 | 22/03/2023 |
Pierre Gravier
DFI | Director of Finance/CFO | 41 | 13/07/2023 |
Lee Golden
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 01/11/2004 | |
Allan Jacobson
BRD | Director/Board Member | 80 | 31/03/1998 |
David Southwell
BRD | Director/Board Member | 65 | 01/12/2005 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.43% | +0.95% | +23.41% | +40.84% | 5.68B | |
| -0.57% | -0.61% | +21.04% | +207.39% | 895B | |
| -0.61% | -1.20% | +46.12% | +58.34% | 587B | |
| +0.41% | -3.24% | +6.99% | +50.40% | 401B | |
| -1.55% | -8.03% | +11.30% | +24.88% | 345B | |
| -0.62% | -5.04% | +26.69% | +62.26% | 300B | |
| -1.16% | -4.00% | +26.17% | +35.54% | 306B | |
| -0.96% | -3.28% | +22.81% | +10.03% | 289B | |
| +0.10% | -0.78% | +18.01% | +61.39% | 202B | |
| -1.41% | -0.86% | +28.41% | +84.81% | 184B | |
| Average | -1.16% | -1.15% | +23.10% | +63.59% | 351.61B | |
| Weighted average by Cap. | -0.75% | -1.89% | +23.96% | +87.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 981M 847M 765M 732M 1.33B 90.43B 1.37B 9.04B 3.6B 43.24B 3.68B 3.6B 156B | 1.16B 1.01B 908M 869M 1.58B 107B 1.63B 10.74B 4.28B 51.34B 4.37B 4.28B 185B |
| Net income | -66.01M -57.04M -51.49M -49.25M -89.76M -6.09B -92.29M -609M -243M -2.91B -248M -242M -10.48B | 89.51M 77.35M 69.83M 66.78M 122M 8.25B 125M 825M 329M 3.95B 336M 329M 14.22B |
| Net Debt | -1.72B -1.48B -1.34B -1.28B -2.33B -158B -2.4B -15.82B -6.31B -75.63B -6.44B -6.3B -272B | -1.88B -1.63B -1.47B -1.4B -2.56B -173B -2.63B -17.35B -6.91B -82.94B -7.06B -6.91B -299B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/03/26 | 65.26 $ | -4.81% | 428,639 |
| 10/03/26 | 68.56 $ | +0.23% | 1,025,110 |
| 09/03/26 | 68.40 $ | +8.88% | 2,494,745 |
| 06/03/26 | 62.82 $ | -0.81% | 1,225,424 |
| 05/03/26 | 63.33 $ | -1.49% | 1,137,040 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PTCT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition